Yinhong Shi

21PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 30, 2026
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization.

|Jun 02, 2026
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCA.

|Dec 19, 2025
DNMT2-m5C-ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation-Mediated Notch Pathway.

Shiguang Yang, Jie Li, Shengwei Mao

|Nov 24, 2025
Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma.

Shiguang Yang, Shaoqing Liu, Jie Li

|Jul 22, 2025
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma.

Tianhao Chu, Guiqi Zhu, Zheng Tang

|May 02, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.

Wei-Feng Qu, Gui-Qi Zhu, Rui Yang

Pageof 4

Frequent Collaborators

7 joint publications

Jian Zhou

5 joint publications

Jia Fan

4 joint publications

Guiqi Zhu

3 joint publications

Weiren Liu